Prothena is laying off almost two-thirds of its workforce as the Irish biotech navigates the fallout from giving up on its failed amyloidosis dr-g.
https://www.fiercebiotech.com/biotech/prothena-lays-63-employees-fallout-phase-3-amyloidosis-dr-g-fail